Johns Hopkins Psychiatry Guide
Methylphenidate
INDICATIONS
FDA
FDA
- Attention deficit hyperactivity disorder (ADHD), narcolepsy (Only the immediate-release formulations are approved for narcolepsy.)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment resistant depression
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 3, 2025
Citation
Weinstein, Sujin L. "Methylphenidate." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787455/6.3/Methylphenidate.
Weinstein SL. Methylphenidate. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787455/6.3/Methylphenidate. Accessed October 8, 2025.
Weinstein, S. L. (2025). Methylphenidate. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787455/6.3/Methylphenidate
Weinstein SL. Methylphenidate [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787455/6.3/Methylphenidate.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylphenidate
ID - 787455
A1 - Weinstein,Sujin,PharmD, BCPP
Y1 - 2025/10/03/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787455/6.3/Methylphenidate
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
